Back

Apixaban for treatment of embolic stroke of undetermined source (ATTICUS) randomized trial - Update of patient characteristics and study timeline after interim analysis

29 August 2021 (20:51 - 21:00)
Organised by:
Congress Presentation Part of: Novel insight into thromboembolic stroke and transient ischemic attack Prevention ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Sven Poli

Eberhard-Karls University of Tubingen, Tuebingen (Germany)

4 More presentations in this session

Presentation thumbnail
Capacities of atrial fibrillation detection after stroke : a French nationwide survey
Doctor C. Guidoux (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Impact of excessive supraventricular ectopic activity detected in the acute phase of stroke or TIA on AF detection and death within 24 months - Results of the prospective MonDAFIS study
Professor K. Haeusler (Ulm, DE)
Abstract Slides Video
Presentation thumbnail
Similarities and differences in risk factors for retinal artery occlusion and stroke.
Ms M. Oerskov (Aalborg, DK)
Abstract Slides Video
Presentation thumbnail
Patient characteristics and clinical outcomes of type 2 myocardial infarction in patients with acute ischemic stroke in the united states
Mr R. Ariss (Toledo, US)
Abstract Slides Video

Access the full session

Session thumbnail
Novel insight into thromboembolic stroke and transient ischemic attack

The Event

Event poster

ESC Congress 2021 - The Digital Experience

29 August 2021 20:51 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources